Drug Type Synthetic peptide |
Synonyms BZ 371A, BZ-371A, PNPP-19 |
Target- |
Action stimulants |
Mechanism Nitric oxide stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Female sexual dysfunction | Phase 2 | Brazil | 01 Jul 2025 | |
Sexual Dysfunctions, Psychological | Phase 2 | Brazil | 01 Oct 2024 | |
Erectile Dysfunction | Phase 2 | Brazil | 22 Nov 2023 | |
Prostatic Cancer | Phase 2 | Brazil | 22 Nov 2023 | |
Diabetic Retinopathy | Preclinical | Brazil | 02 Oct 2020 | |
dry age-related macular degeneration | Preclinical | Brazil | 02 Oct 2020 | |
Glaucoma | Preclinical | Brazil | 02 Oct 2020 | |
Optic Neuropathy, Ischemic | Preclinical | Brazil | 02 Oct 2020 |
Phase 1 | 12 | lswblcwjcg(vfsnktymbl) = lbegxbjhvg gmmolheggi (bglvnozmsa, NA) View more | - | 25 Mar 2025 |